Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

Conditions: Acellular Pertussis; Tetanus; Diphtheria; Haemophilus Influenzae Type bInterventions: Biological: Infanrix+Hib™; Biological: Poliorix™Sponsor: GlaxoSmithKlineCompleted - verified July 2012

http://clinicaltrials.gov/ct2/show/NCT01449812?lup_s=11%2F20%2F2014&lup_d=30

Source: ClinicalTrials.gov - October 6, 2011 Category: Research Source Type: clinical trials